1,035
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Is classical pseudoxanthoma elasticum a consequence of hepatic ‘intoxication’ due to ABCC6 substrate accumulation in the liver?

, &
Pages 37-46 | Published online: 10 Jan 2014

References

  • Uitto J, Li Q, Jiang Q. Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms. J. Invest. Dermatol. 130(3), 661–670 (2010).
  • Plomp AS, Toonstra J, Bergen AA, van Dijk MR, de Jong PT. Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings. Am. J. Med. Genet. A 152A(4), 1049–1058 (2010).
  • Kornet L, Bergen AA, Hoeks AP et al. In patients with pseudoxanthoma elasticum a thicker and more elastic carotid artery is associated with elastin fragmentation and proteoglycans accumulation. Ultrasound Med. Biol. 30(8), 1041–1048 (2004).
  • Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in β thalassemia and the sickling syndromes. Blood 99(1), 30–35 (2002).
  • Vanakker OM, Martin L, Gheduzzi D et al. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J. Invest. Dermatol. 127(3), 581–587 (2007).
  • Nitschke Y, Baujat G, Botschen U et al. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 90(1), 25–39 (2012).
  • Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab. Invest. 82(4), 515–518 (2002).
  • Kool M, van der Linden M, de Haas M, Baas F, Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59(1), 175–182 (1999).
  • Beck K, Hayashi K, Dang K, Hayashi M, Boyd CD. Analysis of ABCC6 (MRP6) in normal human tissues. Histochem. Cell Biol. 123(4–5), 517–528 (2005).
  • Uitto J, Bercovitch L, Terry SF, Terry PF. Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment: summary of the 2010 PXE International Research Meeting. Am. J. Med. Genet. A 155A(7), 1517–1526 (2011).
  • Le Saux O, Fülöp K, Yamaguchi Y et al. Expression and in vivo rescue of human ABCC6 disease-causing mutants in mouse liver. PLoS ONE 6(9), e24738 (2011).
  • Kamata S, Kishimoto T, Kobayashi S, Miyazaki M. Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas. Histopathology 52(6), 747–754 (2008).
  • Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B. Transport function and hepatocellular localization of mrp6 in rat liver. Mol. Pharmacol. 57(3), 634–641 (2000).
  • Gao B, St Pierre MV, Stieger B, Meier PJ. Differential expression of bile salt and organic anion transporters in developing rat liver. J. Hepatol. 41(2), 201–208 (2004).
  • Donner MG, Warskulat U, Saha N, Häussinger D. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol. Chem. 385(3–4), 331–339 (2004).
  • Martin LJ, Lau E, Singh H et al. ABCC6 localizes to the mitochondria-associated membrane. Circ. Res. 111(5), 516–520 (2012).
  • Belinsky MG, Kruh GD. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br. J. Cancer 80(9), 1342–1349 (1999).
  • Slot AJ, Molinski SV, Cole SP. Mammalian multidrug-resistance proteins (MRPs). Essays Biochem. 50(1), 179–207 (2011).
  • Beedholm-Ebsen R, Van de Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood 115(8), 1632–1639 (2010).
  • Iliás A, Urbán Z, Seidl TL et al. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J. Biol. Chem. 277(19), 16860–16867 (2002).
  • Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 62(21), 6172–6177 (2002).
  • Bergen AA, Plomp AS, Schuurman EJ et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet. 25(2), 228–231 (2000).
  • Le Saux O, Urban Z, Tschuch C et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet. 25(2), 223–227 (2000).
  • Struk B, Cai L, Zäch S et al. Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J. Mol. Med. 78(5), 282–286 (2000).
  • Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl Acad. Sci. USA 97(11), 6001–6006 (2000).
  • Miksch S, Lumsden A, Guenther UP et al. Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6. Hum. Mutat. 26(3), 235–248 (2005).
  • Pfendner EG, Vanakker OM, Terry SF et al. Mutation detection in the ABCC6 gene and genotype–phenotype analysis in a large international case series affected by pseudoxanthoma elasticum. J. Med. Genet. 44(10), 621–628 (2007).
  • Gorgels TG, Hu X, Scheffer GL et al. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum. Mol. Genet. 14(13), 1763–1773 (2005).
  • Klement JF, Matsuzaki Y, Jiang QJ et al. Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol. Cell. Biol. 25(18), 8299–8310 (2005).
  • Li Q, Berndt A, Guo H, Sundberg JP, Uitto J. A novel animal model for pseudoxanthoma elasticum: the KK/HlJ mouse. Am. J. Pathol. 181(4), 1190–1196 (2012).
  • Aherrahrou Z, Doehring LC, Ehlers EM et al. An alternative splice variant in Abcc6, the gene causing dystrophic calcification, leads to protein deficiency in C3H/He mice. J. Biol. Chem. 283(12), 7608–7615 (2008).
  • Li Q, Sadowski S, Frank M et al. The abcc6a gene expression is required for normal zebrafish development. J. Invest. Dermatol. 130(11), 2561–2568 (2010).
  • Uitto J, Pulkkinen L, Ringpfeil F. Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment–genome interface? Trends Mol. Med. 7(1), 13–17 (2001).
  • Jiang Q, Oldenburg R, Otsuru S, Grand-Pierre AE, Horwitz EM, Uitto J. Parabiotic heterogenetic pairing of Abcc6-/-/Rag1-/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am. J. Pathol. 176(4), 1855–1862 (2010).
  • Jiang Q, Endo M, Dibra F, Wang K, Uitto J. Pseudoxanthoma elasticum is a metabolic disease. J. Invest. Dermatol. 129(2), 348–354 (2009).
  • Le Saux O, Bunda S, Van Wart CM et al. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J. Invest. Dermatol. 126(7), 1497–1505 (2006).
  • Jiang Q, Li Q, Uitto J. Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J. Invest. Dermatol. 127(6), 1392–1402 (2007).
  • Hu X, Peek R, Plomp A et al. Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum. Invest. Ophthalmol. Vis. Sci. 44(5), 1824–1829 (2003).
  • Quaglino D, Boraldi F, Barbieri D, Croce A, Tiozzo R, Pasquali Ronchetti I. Abnormal phenotype of in vitro dermal fibroblasts from patients with pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta 1501(1), 51–62 (2000).
  • Quaglino D, Sartor L, Garbisa S et al. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim. Biophys. Acta 1741(1–2), 42–47 (2005).
  • Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361(9360), 827–833 (2003).
  • Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Götting C. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin. Chem. 52(2), 227–234 (2006).
  • Jiang Q, Dibra F, Lee MD, Oldenburg R, Uitto J. Overexpression of fetuin-A counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc6(-/-)). J. Invest. Dermatol. 130(5), 1288–1296 (2010).
  • Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386(6620), 78–81 (1997).
  • Gheduzzi D, Boraldi F, Annovi G et al. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 87(10), 998–1008 (2007).
  • Li Q, Jiang Q, Schurgers LJ, Uitto J. Pseudoxanthoma elasticum: reduced γ-glutamyl carboxylation of matrix GLA protein in a mouse model (Abcc6-/-). Biochem. Biophys. Res. Commun. 364(2), 208–213 (2007).
  • Hendig D, Zarbock R, Szliska C, Kleesiek K, Götting C. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin. Biochem. 41(6), 407–412 (2008).
  • Borst P, Van de Wetering K, Schlingemann R. Does the absence of ABCC6 (multidrug resistance protein 6) in patients with pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 7(11), 1575–1579 (2008).
  • Booth SL. Roles for vitamin K beyond coagulation. Annu. Rev. Nutr. 29, 89–110 (2009).
  • Vanakker OM, Martin L, Schurgers LJ et al. Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab. Invest. 90(6), 895–905 (2010).
  • Gorgels TG, Waarsing JH, Herfs M et al. Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum.J. Mol. Med. 89(11), 1125–1135 (2011).
  • Jiang Q, Li Q, Grand-Pierre AE, Schurgers LJ, Uitto J. Administration of vitamin K does not counteract the ectopic mineralization of connective tissues in Abcc6 (-/-) mice, a model for pseudoxanthoma elasticum. Cell Cycle 10(4), 701–707 (2011).
  • Brampton C, Yamaguchi Y, Vanakker O et al. Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum. Cell Cycle 10(11), 1810–1820 (2011).
  • Fülöp K, Jiang Q, Van de Wetering K et al. ABCC6 does not transport vitamin K3–glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxanthoma elasticum. Biochem. Biophys. Res. Commun. 415(3), 468–471 (2011).
  • Markello TC, Pak LK, St Hilaire C et al. Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum. Mol. Genet. Metab. 103(1), 44–50 (2011).
  • St Hilaire C, Ziegler SG, Markello TC et al. NT5E mutations and arterial calcifications. N. Engl. J. Med. 364(5), 432–442 (2011).
  • Szabó Z, Váradi A, Li Q, Uitto J. ABCC6 does not transport adenosine – relevance to pathomechanism of pseudoxanthoma elasticum. Mol. Genet. Metab. 104(3), 421; author reply 422 (2011).
  • Chan AC, Chow CK, Chiu D. Interaction of antioxidants and their implication in genetic anemia. Proc. Soc. Exp. Biol. Med. 222(3), 274–282 (1999).
  • Baccarani-Contri M, Bacchelli B, Boraldi F et al. Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with β-thalassemia. J. Am. Acad. Dermatol. 44(1), 33–39 (2001).
  • Hamlin N, Beck K, Bacchelli B, Cianciulli P, Pasquali-Ronchetti I, Le Saux O. Acquired pseudoxanthoma elasticum-like syndrome in β-thalassaemia patients. Br. J. Haematol. 122(5), 852–854 (2003).
  • Martin L, Douet V, VanWart CM, Heller MB, Le Saux O. A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression. Am. J. Pathol. 178(2), 774–783 (2011).
  • Pasquali-Ronchetti I, Garcia-Fernandez MI, Boraldi F et al. Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations. J. Pathol. 208(1), 54–61 (2006).
  • Boraldi F, Annovi G, Guerra D et al. Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum. Proteomics. Clin. Appl. 3(9), 1084–1098 (2009).
  • Garcia-Fernandez MI, Gheduzzi D, Boraldi F et al. Parameters of oxidative stress are present in the circulation of PXE patients. Biochim. Biophys. Acta 1782(7–8), 474–481 (2008).
  • Li Q, Jiang Q, Uitto J. Pseudoxanthoma elasticum: oxidative stress and antioxidant diet in a mouse model (Abcc6-/-). J. Invest. Dermatol. 128(5), 1160–1164 (2008).
  • Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C. Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin. Chem. 53(10), 1734–1740 (2007).
  • Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 109(8), 3161–3172 (2007).
  • Rutsch F, Ruf N, Vaingankar S et al. Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat. Genet. 34(4), 379–381 (2003).
  • Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human α 2 HS glycoprotein during the inflammatory process: evidence that α 2 HS glycoprotein is a negative acute-phase reactant. J. Clin. Invest. 64(4), 1118–1129 (1979).
  • Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW. Hemoglobin. A biologic Fenton reagent. J. Biol. Chem. 259(23), 14354–14356 (1984).
  • Douet V, VanWart CM, Heller MB, Reinhard S, Le Saux O. HNF4α and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. Biochim. Biophys. Acta 1759(8–9), 426–436 (2006).
  • Hayashi T, Rizzuto R, Hajnoczky G, Su TP. MAM: more than just a housekeeper. Trends Cell Biol. 19(2), 81–88 (2009).
  • Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am. J. Ophthalmol. 152(4), 695–703 (2011).
  • Bercovitch L, Martin L, Chassaing N et al. Acquired pseudoxanthoma elasticum presenting after liver transplantation. J. Am. Acad. Dermatol. 64(5), 873–878 (2011).
  • Van de Wetering K, Feddema W, Helms JB, Brouwers JF, Borst P. Targeted metabolomics identifies glucuronides of dietary phytoestrogens as a major class of MRP3 substrates in vivo. Gastroenterology 137(5), 1725–1735 (2009).
  • Krumpochova P, Sapthu S, Brouwers JF et al. Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. FASEB J. 26(2), 738–747 (2012).
  • Van de Wetering K, Sapthu S. ABCG2 functions as a general phytoestrogen sulfate transporter in vivo. FASEB J. 26(10), 4014–4024 (2012).
  • Li Q, Larusso J, Grand-Pierre AE, Uitto J. Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice–potential for treatment of pseudoxanthoma elasticum. Clin. Transl. Sci. 2(6), 398–404 (2009).
  • LaRusso J, Li Q, Jiang Q, Uitto J. Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-)). J. Invest. Dermatol. 129(6), 1388–1394 (2009).
  • Gorgels TG, Waarsing JH, de Wolf A, ten Brink JB, Loves WJ, Bergen AA. Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum. J. Mol. Med. 88(5), 467–475 (2010).
  • Jiang Q, Uitto J. Restricting dietary magnesium accelerates ectopic connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-)). Exp. Dermatol. 21(9), 694–699 (2012).
  • Kupetsky-Rincon EA, Li Q, Uitto J. Magnesium reduces carotid intima-media thickness in a mouse model of pseudoxanthoma elasticum: a novel treatment biomarker. Clin. Transl. Sci. 5(3), 259–264 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.